Literature DB >> 21767645

Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses.

Brandi M Wynne1, Hicham Labazi, Rita C Tostes, R Clinton Webb.   

Abstract

Hypertension is a disorder affecting millions worldwide, and is a leading cause of death and debilitation in the United States. It is widely accepted that during hypertension and other cardiovascular diseases the vasculature exhibits endothelial dysfunction; a deficit in the relaxatory ability of the vessel, attributed to a lack of nitric oxide (NO) bioavailability. Recently, the one electron redox variant of NO, nitroxyl anion (NO(-)) has emerged as an endothelium-derived relaxing factor (EDRF) and a candidate for endothelium-derived hyperpolarizing factor (EDRF). NO(-) is thought to exist protonated (HNO) in vivo, which would make this species more resistant to scavenging. However, no studies have investigated the role of this redox species during hypertension, and whether the vasculature loses the ability to relax to HNO. Thus, we hypothesize that aorta from angiotensin II (AngII)-hypertensive mice will exhibit a preserved relaxation response to Angeli's Salt, an HNO donor. Male C57Bl6 mice, aged 12-14 weeks were implanted with mini-osmotic pumps containing AngII (90ng/min, 14 days plus high salt chow) or sham surgery. Aorta were excised, cleaned and used to perform functional studies in a myograph. We found that aorta from AngII-hypertensive mice exhibited a significant endothelial dysfunction as demonstrated by a decrease in acetylcholine (ACh)-mediated relaxation. However, vessels from hypertensive mice exhibited a preserved response to Angeli's Salt (AS), the HNO donor. To confirm that relaxation responses to HNO were maintained, concentration response curves (CRCs) to ACh were performed in the presence of scavengers to both NO and HNO (carboxy-PTIO and L-cys, resp.). We found that ACh-mediated relaxation responses were significantly decreased in aorta from sham and almost completely abolished in aorta from AngII-treated mice. Vessels incubated with l-cys exhibited a modest decrease in ACh-mediated relaxations responses. These data demonstrate that aorta from AngII-treated hypertensive mice exhibit a preserved relaxation response to AS, an HNO donor, regardless of a significant endothelial dysfunction.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21767645      PMCID: PMC3908541          DOI: 10.1016/j.phrs.2011.07.002

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  45 in total

1.  Comparison of the redox forms of nitrogen monoxide with the nitrergic transmitter in the rat anococcygeus muscle.

Authors:  C G Li; J Karagiannis; M J Rand
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

Review 2.  The physiological chemistry and biological activity of nitroxyl (HNO): the neglected, misunderstood, and enigmatic nitrogen oxide.

Authors:  Jon M Fukuto; Michael D Bartberger; Andrew S Dutton; Nazareno Paolocci; David A Wink; K N Houk
Journal:  Chem Res Toxicol       Date:  2005-05       Impact factor: 3.739

3.  The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature.

Authors:  Joanne L Favaloro; Barbara K Kemp-Harper
Journal:  Cardiovasc Res       Date:  2006-11-18       Impact factor: 10.787

Review 4.  The activation of metabolites of nitric oxide synthase by metals is both redox and oxygen dependent: a new feature of nitrogen oxide signaling.

Authors:  Sonia Donzelli; Christopher H Switzer; Douglas D Thomas; Lisa A Ridnour; Michael Graham Espey; Jeffrey S Isenberg; Carlo G Tocchetti; S Bruce King; Giuseppe Lazzarino; Katrina M Miranda; David D Roberts; Martin Feelisch; David A Wink
Journal:  Antioxid Redox Signal       Date:  2006 Jul-Aug       Impact factor: 8.401

Review 5.  Nitroxyl (HNO): chemistry, biochemistry, and pharmacology.

Authors:  Jon M Fukuto; Christopher H Switzer; Katrina M Miranda; David A Wink
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

6.  Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.

Authors:  Johannes-Peter Stasch; Peter M Schmidt; Pavel I Nedvetsky; Tatiana Y Nedvetskaya; Arun Kumar H S; Sabine Meurer; Martin Deile; Ashraf Taye; Andreas Knorr; Harald Lapp; Helmut Müller; Yagmur Turgay; Christiane Rothkegel; Adrian Tersteegen; Barbara Kemp-Harper; Werner Müller-Esterl; Harald H H W Schmidt
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

Review 7.  Inflammation in hypertension.

Authors:  Carmine Savoia; Ernesto L Schiffrin
Journal:  Curr Opin Nephrol Hypertens       Date:  2006-03       Impact factor: 2.894

8.  Discriminating formation of HNO from other reactive nitrogen oxide species.

Authors:  Sonia Donzelli; Michael Graham Espey; Douglas D Thomas; Daniele Mancardi; Carlo G Tocchetti; Lisa A Ridnour; Nazareno Paolocci; S Bruce King; Katrina M Miranda; Giuseppe Lazzarino; Jon M Fukuto; David A Wink
Journal:  Free Radic Biol Med       Date:  2005-11-21       Impact factor: 7.376

9.  Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors.

Authors:  Eunji Cheong; Vassil Tumbev; Jon Abramson; Guy Salama; Detcho A Stoyanovsky
Journal:  Cell Calcium       Date:  2005-01       Impact factor: 6.817

10.  Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling.

Authors:  Carlo G Tocchetti; Wang Wang; Jeffrey P Froehlich; Sabine Huke; Miguel A Aon; Gerald M Wilson; Giulietta Di Benedetto; Brian O'Rourke; Wei Dong Gao; David A Wink; John P Toscano; Manuela Zaccolo; Donald M Bers; Hector H Valdivia; Heping Cheng; David A Kass; Nazareno Paolocci
Journal:  Circ Res       Date:  2006-11-30       Impact factor: 17.367

View more
  12 in total

Review 1.  Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome.

Authors:  Hicham Labazi; Aaron J Trask
Journal:  Pharmacol Res       Date:  2017-07-09       Impact factor: 7.658

2.  Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes.

Authors:  Marianne Tare; Rushita S R Kalidindi; Kristen J Bubb; Helena C Parkington; Wee-Ming Boon; Xiang Li; Christopher G Sobey; Grant R Drummond; Rebecca H Ritchie; Barbara K Kemp-Harper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-10       Impact factor: 3.000

Review 3.  New insights into the role of soluble guanylate cyclase in blood pressure regulation.

Authors:  Emmanuel Buys; Patrick Sips
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-03       Impact factor: 2.894

4.  Protein kinase Cα deletion causes hypotension and decreased vascular contractility.

Authors:  Brandi M Wynne; Cameron G McCarthy; Theodora Szasz; Patrick A Molina; Arlene B Chapman; R Clinton Webb; Janet D Klein; Robert S Hoover
Journal:  J Hypertens       Date:  2018-03       Impact factor: 4.844

5.  Effect of angiotensin II-induced arterial hypertension on the voltage-dependent contractions of mouse arteries.

Authors:  Paul Fransen; Cor E Van Hove; Arthur J A Leloup; Dorien M Schrijvers; Guido R Y De Meyer; Gilles W De Keulenaer
Journal:  Pflugers Arch       Date:  2015-10-03       Impact factor: 3.657

6.  Angeli's Salt, a nitroxyl anion donor, reverses endothelin-1 mediated vascular dysfunction in murine aorta.

Authors:  Brandi M Wynne; Hicham Labazi; Zidonia N Carneiro; Rita C Tostes; R Clinton Webb
Journal:  Eur J Pharmacol       Date:  2017-08-20       Impact factor: 4.432

7.  Nitroxyl donors retain their depressor effects in hypertension.

Authors:  Jennifer C Irvine; Ravina M Ravi; Barbara K Kemp-Harper; Robert E Widdop
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-12       Impact factor: 4.733

8.  Interaction among Hydrogen Sulfide and Other Gasotransmitters in Mammalian Physiology and Pathophysiology.

Authors:  Ya-Qian Huang; Hong-Fang Jin; Heng Zhang; Chao-Shu Tang; Jun-Bao Du
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects.

Authors:  Sonia Donzelli; Gerry Fischer; Bruce S King; Christin Niemann; Jenna F DuMond; Jörg Heeren; Hartwig Wieboldt; Stephan Baldus; Christian Gerloff; Thomas Eschenhagen; Lucie Carrier; Rainer H Böger; Michael Graham Espey
Journal:  J Pharmacol Exp Ther       Date:  2012-12-04       Impact factor: 4.030

10.  Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO•) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation.

Authors:  Barbara K Kemp-Harper; Anida Velagic; Nazareno Paolocci; John D Horowitz; Rebecca H Ritchie
Journal:  Handb Exp Pharmacol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.